DE69831084D1 - Beta-defensine - Google Patents

Beta-defensine

Info

Publication number
DE69831084D1
DE69831084D1 DE69831084T DE69831084T DE69831084D1 DE 69831084 D1 DE69831084 D1 DE 69831084D1 DE 69831084 T DE69831084 T DE 69831084T DE 69831084 T DE69831084 T DE 69831084T DE 69831084 D1 DE69831084 D1 DE 69831084D1
Authority
DE
Germany
Prior art keywords
beta
defensins
zampl
polypeptides
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69831084T
Other languages
English (en)
Other versions
DE69831084T2 (de
Inventor
David Adler
L Holloway
Nand Baindur
Stephanie Beigel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DE69831084D1 publication Critical patent/DE69831084D1/de
Publication of DE69831084T2 publication Critical patent/DE69831084T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Gyroscopes (AREA)
  • Silicon Polymers (AREA)
  • Photoreceptors In Electrophotography (AREA)
DE69831084T 1997-09-10 1998-09-10 Beta-defensine Expired - Fee Related DE69831084T2 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US5833597P 1997-09-10 1997-09-10
US92652997A 1997-09-10 1997-09-10
US58335P 1997-09-10
US926529 1997-09-10
US6429497P 1997-11-05 1997-11-05
US96468797A 1997-11-05 1997-11-05
US64294P 1997-11-05
US964687 1997-11-05
PCT/US1998/019222 WO1999013080A1 (en) 1997-09-10 1998-09-10 Beta-defensins

Publications (2)

Publication Number Publication Date
DE69831084D1 true DE69831084D1 (de) 2005-09-08
DE69831084T2 DE69831084T2 (de) 2006-06-01

Family

ID=27489968

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69831084T Expired - Fee Related DE69831084T2 (de) 1997-09-10 1998-09-10 Beta-defensine

Country Status (8)

Country Link
EP (1) EP1012285B1 (de)
JP (1) JP2001515720A (de)
AT (1) ATE301194T1 (de)
AU (1) AU744152B2 (de)
CA (1) CA2303421C (de)
DE (1) DE69831084T2 (de)
DK (1) DK1012285T3 (de)
WO (1) WO1999013080A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2371794C (en) * 1999-02-01 2013-10-29 Enno Christophers Human antibiotic proteins
US6335318B1 (en) * 1999-05-10 2002-01-01 The Regents Of The University Of California Antimicrobial theta defensins and methods of using same
WO2001030846A1 (en) * 1999-10-28 2001-05-03 Zymogenetics, Inc. Beta-defensins
DE19957043A1 (de) * 1999-11-26 2001-06-07 Forssmann Wolf Georg Neue Defensine
AU2001275208A1 (en) * 2000-06-01 2001-12-11 University Of Iowa Research Foundation Human beta-defensin-3 (hbd-3), a highly cationic beta-defensin antimicrobial peptide
EP1299541B1 (de) * 2000-07-11 2007-09-12 IPF Pharmaceuticals GmbH Verfahren zur gewinnung und anwendung neuer humaner defensine als biologisch aktive eiweisstoffe zur behandlung von infektionen und anderen erkrankungen
AU2002227925A1 (en) * 2000-11-14 2002-05-27 Ipf Pharmaceuticals Gmbh Human beta-defensin-3
US7119070B2 (en) 2002-04-30 2006-10-10 The Regents Of The University Of California Antimicrobial theta defensins, analogs thereof, and methods of use
GB0223655D0 (en) * 2002-10-10 2002-11-20 Mabtech Ab Method of diagnosis
FR2879203A1 (fr) * 2004-12-09 2006-06-16 Univ Rennes I Etablissement Pu Peptides antimicrobiens, polypeptides comprenant lesdits peptides, procedes pour les preparer, genes codant pour lesdits peptides, vecteurs, organismes transformes et compositions les contenant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550109A (en) * 1994-05-24 1996-08-27 Magainin Pharmaceuticals Inc. Inducible defensin peptide from mammalian epithelia
EP1000152A2 (de) * 1997-08-01 2000-05-17 Genset 5' ests für sekretierte proteine, die im muskel und anderen mesodermalen geweben exprimiert werden

Also Published As

Publication number Publication date
AU744152B2 (en) 2002-02-14
WO1999013080A1 (en) 1999-03-18
ATE301194T1 (de) 2005-08-15
DE69831084T2 (de) 2006-06-01
EP1012285A1 (de) 2000-06-28
EP1012285B1 (de) 2005-08-03
JP2001515720A (ja) 2001-09-25
DK1012285T3 (da) 2005-12-12
AU9391598A (en) 1999-03-29
CA2303421C (en) 2005-07-12
CA2303421A1 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
NO20000934D0 (no) Adipocyttspesifikke proteinhomologer
DE69435307D1 (de) Bazillus Thuringiensis und dessen insektizide Proteine
BR9504791B1 (pt) composto de polipeptìdeo e composição farmacêutica.
DE69922822D1 (de) Rekombinante haarbehandlungsmittel
NZ263344A (en) Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use
IL134011A0 (en) Adipocyte-specific protein homologs
DE69831084D1 (de) Beta-defensine
ATE296312T1 (de) Metalkomplexbildner
EE05497B1 (et) Polüpeptiid, lahustuv CRAM-1 polüpeptiid, polünukleotiid ja antikeha
ES2072868T3 (es) Proteina capaz de unir la fibronectina y su preparacion.
ATE313562T1 (de) Antimicrobielle wirkung des ersten kationischen cluster des menschlichen lactoferrins
DE69622259T2 (de) Cd40 bindendes protein zur stimulierung der immunantwort
DK1169340T3 (da) Lantibiotikum
DE3850433D1 (de) Allergiebehandlung und Zusammensetzung dafür.
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
DK0968288T3 (da) z219a, en human homolog til 2-19 protein
NO922421D0 (no) Collagenbindende protein, samt fremstilling derav
ATE550345T1 (de) Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
BR0007816A (pt) Fator de estimulação óssea
WO2000073446A3 (en) Adipocyte complement related protein homolog zacrp6
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
DK0999849T3 (da) Anvendelse af LBP til sepsisbehandling
DE69002821D1 (de) Zusammensetzung zur haarbehandlung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee